Sharon H. Giordano

Feb 3, 2025 | thelancet.com | Juan Ruiz |Sharon H. Giordano |Heather Lin |Maria E. Suarez-Almazor

Get full text accessLog in, subscribe or purchase for full access. References1. Balkwill, FTumour necrosis factor and cancerNat Rev Cancer. 2009; 9:361-3712. Chen, AY ∙ Wolchok, JD ∙ Bass, ARTNF in the era of immune checkpoint inhibitors: friend or foe? Nat Rev Rheumatol. 2021; 17:213-2233. Annese, V ∙ Beaugerie, L ∙ Egan, L ∙ et al. European evidence-based consensus: inflammatory bowel disease and malignanciesJ Crohns Colitis. 2015; 9:945-9654. Gordon, H ∙ Biancone, L ∙ Fiorino, G ∙ et al.

Oct 1, 2024 | mdanderson.org | Sharon H. Giordano

Breast cancer develops from cells in the breast tissue. It is often thought of as a woman's disease. But men can get breast cancer, too. How common is male breast cancer? And how is it treated? Here, I’ll answer these questions and more about male breast cancer. How common is male breast cancer? Male breast cancer represents about 1% of all breast cancer cases in the United States. Every male has about a 1 in 1,000 risk of developing breast cancer in their lifetime. What causes male breast cancer?

Sep 4, 2024 | digitalcommons.library.tmc.edu | Emily Jones |Zhigang Duan |Thinh Nguyen |Sharon H. Giordano

Adjuvant chemotherapy of leucovorin-modulated 5-fluorouracil (5-FU/LV), capecitabine, and adding oxaliplatin to 5-FU/LV or capecitabine (FLOX/OX) have been standard regimens for high-risk stage II or III colon cancer (CC). We aimed to evaluate their patterns of use, association with survival, and rate of emergency room visit (ER) or hospitalization during the treatment period.

Sep 4, 2024 | digitalcommons.library.tmc.edu | Zhaoli Liu |Yong-Fang Kuo |Sharon H. Giordano

PURPOSE: To examine the trends of racial/ethnic and urban-rural disparities in screening mammography use with a focus on Hispanic women in rural Texas, as well as to further investigate barriers to mammography screening practices. METHODS: A serial cross-sectional study was conducted on screening mammography including eligible female respondents (≥ 40 years) from the Texas Behavioral Risk Factor Surveillance System survey from 2002 to 2018.

Sep 4, 2024 | digitalcommons.library.tmc.edu | Zhaoli Liu |Yong Shan |Yong-Fang Kuo |Sharon H. Giordano

This study examined rural racial/ethnic disparities in long-term mammography screening practices among Medicare beneficiaries. A retrospective longitudinal study was conducted using 100% Texas Medicare data for women aged 65-74 who enrolled in Medicare between 2010-2013.